Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 16:05 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
October 29, 2025 07:00 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major...
October 28, 2025 07:00 ET | Source: Lifecore Biomedical, Inc.; PolyPeptide Laboratories, Inc.

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization...
October 27, 2025 05:02 ET | Source: Research and Markets

U.S. Investigational New Drug CDMO Market Trends Analysis Report with Growth Forecasts for 2025-2033

Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "U.S. Investigational New Drug CDMO Market Size, Share & Trends Analysis Report by Service (Contract Development, Contract Manufacturing), End Use...
October 21, 2025 11:26 ET | Source: Research and Markets

Investigational New Drug CDMO Market Size, Share & Trends Analysis Report, with Growth Forecasts, 2025-2033

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Investigational New Drug CDMO Market Size, Share & Trends Analysis Report by Service (Contract Development, Contract Manufacturing), End Use...
October 21, 2025 10:04 ET | Source: Research and Markets

U.S. Large Molecule Drug Substance CDMO Market Analysis Report, with Growth Forecasts for 2025-2033

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Large Molecule Drug Substance CDMO Market Size, Share & Trends Analysis Report by Product (Biologics, Biosimilar), Service (Contract...
October 15, 2025 04:04 ET | Source: Research and Markets

Pharmaceutical Contract Manufacturing Market Research 2025-2030: GLP-1 Capacity Crunch, Expansion in Emerging Countries, Booming Radiopharmaceutical and Nuclear Medicine Segment Fuel Expansion

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule), Biologics (API,...
October 13, 2025 07:00 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

CHASKA, Minn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
September 25, 2025 08:00 ET | Source: Cosmos Health Inc.

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Cosmos Health expands order book with contract to manufacture 3 million units of MYCOFAGYL® pessaries, broadening its portfolio into gynecology.
September 23, 2025 16:30 ET | Source: Lifecore Biomedical, Inc.

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today...